🔗 Share this article

An underground economy for unapproved weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.

Experimental Drug Acquiring Popularity Online

Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its supposed weight-reducing effects. Viewers are urged to message these profiles privately for supplier links, while also receiving promotional offers.

Active Trade on Social Networks

Separately, a flourishing trade exists on Telegram, where groups with numerous of participants share “before and after” photos, administration instructions and claims of rapid UK delivery. Sellers market the substance there before redirecting buyers to other platforms for purchases.

Learning About The Experimental Drug

Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.

Medical Professionals Voice Concerns

However, physicians and pharmacists have cautions that the distribution of what remains an unapproved drug in the UK is a cause for concern and could lead to individuals injecting products of unknown origin.

Several experts said the demand for retatrutide could be linked to the increasing price of licensed slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unapproved medication that cannot be marketed or distributed for human use under the British medical regulations.

Some content creators attempt to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still breach medicines, marketing, and consumer laws, risking fines, prosecution or prison.

Service Reaction and Material Removal

Based on the social media company, the platform has removed problematic content and prohibited related hashtags and query recommendations. The organization said it was committed to maintaining the service safe and investing in strengthening compliance measures.

Digital Trading Operations

Research also discovered communities with up to 9,000 participants marketing the experimental drug using Telegram's integrated discovery tool, which operates like a public directory. Typing “retatrutide” instantly brings up groups with thousands of users, populated with images of slimming results, glowing testimonials and detailed instructions for preparing or administering at residence.

Within minutes of joining one group, a vendor posted contact information, where the majority of purchases take place. The seller provided an instruction manual and promised delivery within two days. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None inquired about body mass, medical conditions or past usage.

Product Details and Costs

Inside these groups, messages display black plastic parcels with postal service labels, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at residence with purified liquid, or ready-to-use injectors typically sold at 160 pounds for 20mg. When asked how much time a pen should last, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A spokesperson for Telegram stated it regularly monitored dangerous content on its service including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are administering substances they cannot confirm. Even if the research behind this drug is valid, these online versions may not include what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the increase in demand to current price rises for approved weight-loss drugs such as Mounjaro. “With prices increasing, individuals are using social media. But counterfeit treatments are highly dangerous. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she said.

Her staff has previously encountered individuals harmed by self-injection from unverified sources. “We recognize the disappointment, but buying from messaging apps or communication platforms is gambling with your health,” stated the doctor. “These substances could be impure or incorrectly dosed.”

Manufacturer Position

A spokesperson from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this point no one can market [it] for human use,” they said, adding that any product “falsely representing itself as a Lilly investigational product not yet approved … may expose users to potentially significant health risks”.